Evidence map›Paper›PMID 39581593›Full record

ArticleJournal of epidemiology2025

Impact of the COVID-19 Pandemic on Changes in Tobacco Use Behavior: A Longitudinal Cohort Study in Japan.

Makiko Kanai, Osamu Kanai, Takahiro Tabuchi

Abstract read
In one paragraph

Article in Journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Makiko KanaiDivision of Respiratory Medicine, National Hospital Organization Kyoto Medical Center.ORCID 0000-0002-7355-0068
Osamu KanaiDivision of Respiratory Medicine, National Hospital Organization Kyoto Medical Center.
Takahiro TabuchiDepartment of Cancer Epidemiology, Osaka International Cancer Institute Cancer Control Center.ORCID 0000-0002-1050-3125

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUse of novel tobacco products, such as heated tobacco products, has recently increased as a result of being promoted less harmful alternatives to cigarettes. The impact of the coronavirus disease 2019 (COVID-19) pandemic on tobacco use may differ depending on the type of tobacco.

methodsWe longitudinally investigated changes in tobacco use over a 1-year period using internet-based and self-reported questionnaires among Japanese aged 15 to 79 years. The study was conducted from 2019 to 2021, with participants before the COVID-19 pandemic in February 2020 as the pre-pandemic group and participants after that as the pandemic group. Accounting for population bias, we used sampling probability weighting referring to the nationwide data. The association between cessation and the COVID-19 pandemic was evaluated separately for each type of tobacco using logistic regression analysis.

resultsAfter conducting sampling probability weighting, 1,920 were in the pre-pandemic group and 2,681 were in the pandemic group. More participants in the pandemic group than in the pre-pandemic group achieved cessation after 1 year (13.8% vs 10.2%, P < 0.001). Dual users were more likely to quit during the pandemic than pre-pandemic (adjusted odds ratio [aOR] 2.56, P < 0.001), whereas exclusive novel tobacco users were less likely to quit during the pandemic (aOR 0.66, P = 0.041). Tobacco cessation was more frequently achieved among those who had intended to quit at baseline survey among conventional tobacco users (aOR 1.77, P < 0.001) and dual users (aOR 2.52, P < 0.001); however, this trend was not observed among novel tobacco users (aOR 1.49, P = 0.090).

conclusionConventional and novel tobacco use patterns varied in response to the COVID-19 pandemic.

Indexed as

COVID-19Smoking CessationTobacco UseAdolescentAdultAgedFemaleHumansJapanLongitudinal StudiesMaleMiddle AgedPandemicsSurveys and QuestionnairesYoung AdultCOVID-19 pandemicheated tobacco productstobacco cessation

Identifiers

PMID39581593
PMCPMC12066193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.